BackETF Series Solutions Trust - Defiance Nasdaq Junior Biotechnology ETF Overview
ETF Series Solutions Trust - Defiance Nasdaq Junior Biotechnology ETF

ETF Series Solutions Trust - Defiance Nasdaq Junior Biotechnology ETF Return on Equity

Latest ROE for ETF Series Solutions Trust - Defiance Nasdaq Junior Biotechnology ETF: -24.4% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-24.40%

Return on Equity

-24.40%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

ETF Series Solutions Trust - Defiance Nasdaq Junior Biotechnology ETF (IBBJ) FAQ

As of the most recent data, IBBJ shows a ROE of -24.4%. That is below the sector sector average of -4.47%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about -4.47%. ETF Series Solutions Trust - Defiance Nasdaq Junior Biotechnology ETF is at -24.4%, which is lower that average. That is roughly 446.1% below the sector mean. Use the comparison chart on this page to see how IBBJ stacks up against individual peers as well.

Check the historical chart to see whether IBBJ's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare ETF Series Solutions Trust - Defiance Nasdaq Junior Biotechnology ETF with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has ETF Series Solutions Trust - Defiance Nasdaq Junior Biotechnology ETF's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -24.4%) with ownership activity and broader fundamentals.